Skip to main content
. 2018 Sep 30;20(3):362–372. doi: 10.5853/jos.2018.00605

Table 3.

Patient characteristics stratified by outcome

Characteristic Patients with favorable outcome (90-day mRS ≤1) (n=33) Patients with unfavorable outcome (90-day mRS ≥2) (n=69) P
Age (yr) 67 (58–76) 77 (68–81) <0.01
Time from symptom onset to admission (min) 75 (51–107) 98 (60–177) 0.20
Comorbidities
 Hyperlipidemia 17 (51.5) 26 (38.2) 0.28
 Hypertension 20 (60.6) 57 (82.6) 0.03
 Diabetes 7 (21.9) 17 (25) 0.81
 PAD 1 (3) 7 (10.4) 0.27
Stroke etiology
 Large artery atherosclerosis 2 (6.1) 5 (7.5) 1
 Cardioembolic 18 (54.5) 34 (50.7) 0.83
 ESUS 4 (12.1) 8 (11.9) 1
 Other 3 (9.1) 2 (3) 0.33
 Unknown 6 (18.2) 18 (26.9) 0.46
Clinical scores
 NIHSS admission 13 (8.8–17.3) 18 (12–20) 0.03
 mRS admission 4 (3–5) 5 (4–5) 0.01
Occlusion sites
 Proximal ICA 0 (0) 1 (1.4) 1
 Distal ICA 3 (9.1) 21 (30.4) 0.03
 MCA 30 (90.9) 47 (68.1) 0.01
Imaging scores
 NECT-ASPECTS 9 (8–9.3) 8 (7–9) <0.01
CTP
 CBV-ASPECTS 8 (7–9) 7 (5–8) <0.01
 CBF-ASPECTS 4 (2.8–5) 3 (1–5) 0.05
 TTD-ASPECTS 3 (1–4) 1 (0–3) <0.01
 MTT-ASPECTS 3 (2–5) 2 (0.8–3) <0.01
 ΔCBV-CBF-ASPECTS 3 (2.8–5.3) 3 (1.8–4) 0.08
 ΔCBV-TTD-ASPECTS 5 (4–6) 4 (3–6) 0.17
 ΔCBV-MTT-ASPECTS 5 (4–6) 4 (3–6) 0.19
Collaterals
 rLMC score 15 (12–16) 12.5 (10–14) <0.01
 sp Menon score (CTA) 8 (6–9) 6 (4.8–8) <0.01
 sp Menon score (tMIP) 8.5 (7–9) 7 (6–8) <0.01
 mp Menon score 7 (6–8) 7 (5–8) 0.03
 mod mp Menon score 7.5 (6–8) 7 (6–8) 0.06

Values are presented as median (interquartile range) or number (%). A 90-day mRS ≤1 was defined as favorable outcome, while a 90-day mRS >1 was considered unfavorable.

mRS, modified Rankin Scale; PAD, peripheral artery disease; ESUS, embolic stroke of undetermined source; NIHSS, National Institute of Health Stroke Scale; ICA, internal carotid artery; MCA, middle cerebral artery; NECT, non-enhanced computed tomography (CT); ASPECTS, Alberta Stroke Program Early CT Score; CTP, CT perfusion; CBV, cerebral blood volume; CBF, cerebral blood flow; TTD, time to drain; MTT, mean transit time; rLMC score, regional leptomeningeal collateral score; sp Menon score, single-phase Menon score; CTA, CT angiography; tMIP, temporal maximal intensity projection; mp Menon score, multi-phase Menon score; mod mp Menon score; modified multi-phase Menon score.